Please login to the form below

Not currently logged in
Email:
Password:

mongersen

This page shows the latest mongersen news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more

Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more

The company’s psoriasis drug Otezla is also underperforming, and another blockbuster candidate mongersen failed in phase III.

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

The UK has approved the first vaccine for COVID-19. What now?
The authorisation of Pfizer/BioNtech's mRNA vaccine by the MHRA is great news, but no-one has ever tried to roll out a vaccine as rapidly as this one, so we have...
Clinical trials and the diversity principle
If they were ever really hidden, 2020 revealed the expensive-sounding problems limiting diversity in clinical trials. Solutions are overdue....
marketing satnav
Mapping at launch: it’s time to update the satnav
How mapping familiar basics can provide a new GPS for market access strategy that drives brand success...

Infographics